Figure 2
Overall survival (A) and recurrence/metastasis-free survival (B) according to ER negative; overall survival (C) and recurrence/metastasis-free survival (D) according to PR negative; overall survival (E) and recurrence/metastasis-free survival (F) according to HR negative; overall survival (G) and recurrence/metastasis-free survival (H) in HER2/neu negative. *Adjusted for tumor size (ā¤2 vs.ā>2 cm) and lymph node status (positive vs. negative).